1 Bray F,Laversanne M,Sung H,et al.Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2024,74(3):229-263. 2 Chandra A,Pius C,Nabeel M,et al.Ovarian cancer:Current status and strategies for improving therapeutic outcomes[J].Cancer Med,2019,8(16):7018-7031. 3 Hanahan D,Weinberg RA.Hallmarks of cancer:the next generation[J].Cell,2011,144(5):646-674. 4 Guo C,You Z,Shi H,et al.SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity[J].Nature,2023,620(7972):200-208. 5 Li J,Zheng C,Mai QH,et al.Tyrosine catabolism enhances genotoxic chemotherapy by suppressing translesion DNA synthesis in epithelial ovarian cancer[J].Cell Metab,2023,35(11):2044-2059. 6 Qiu Y,Su Y,Xie E,et al.Mannose metabolism reshapes T cell differentiation to enhance anti-tumor immunity[J].Cancer Cell,2025,43(1):103-121.e8. 7 Xiong L,Yang X,Liu H,et al.Glutamic-pyruvic transaminase 1 deficiency-mediated metabolic reprogramming facilitates colorectal adenoma-carcinoma progression[J].Sci Transl Med,2025,17(779):eadp9805. 8 Tejero JD,Hesterberg RS,Drapela S,et al.Methylmalonic acid induces metabolic abnormalities and exhaustion in CD8+T cells to suppress anti-tumor immunity[J].Oncogene,2024,44(2):105-114. 9 Wang P,Ma J,Li W,eta al.Profiling the metabolome of uterine fluid for early detection of ovarian cancer[J].Cell Rep Med,2023,4(6):101061. 10 Ference BA,Holmes MV,Smith GD.Using mendelian randomization to improve the design of randomized trials[J].CSH Perspect Med,2021,11(7):a040980. 11 Davey Smith G,Hemani G.Mendelian randomization:genetic anchors for causal inference in epidemiological studies[J].Hum Mol Genet,2014,23(R1):R89-R98. 12 Bowden J,Davey Smith G,Burgess S.Mendelian randomization with invalid instruments:effect estimation and bias detection through Egger regression[J].Int J Epidemiol,2015,44(2):512-525. 13 Burgess S,Butterworth A,Thompson SG.Mendelian randomization analysis with multiple genetic variants using summarized data[J].Genet Epidemiol,2013,37(7):658-665. 14 Burgess S,Davies NM,Thompson SG.Bias due to participant overlap in two-sample Mendelian randomization[J].Genet Epidemiol,2016,40(7):597-608. 15 Holmes MV,Ala-Korpela M,Smith GD.Mendelian randomization in cardiometabolic disease:challenges in evaluating causality[J].Nat Rev Cardiol,2017,14(10):577-590. 16 Yamamoto T,Koyama H,Kurajoh M,et al.Biochemistry of uridine in plasma[J].Clinica Chimica Acta,2011,412(19-20):1712-1724. 17 Arbour CA,Imperiali B.Uridine natural products:Challenging targets and inspiration for novel small molecule inhibitors[J].Bioorg Med Chem,2020,28(18):115661. 18 Peters GJ,Dijk JV,Groeningen CV,et al.Toxicity and antitumor effect of 5-fluorouracil and its rescue by uridine[J].Adv Exp Med Biol,1986,195 Pt B:121-128. 19 Walker UA,Venhoff N,Koch EC,et al.Uridine abrogates mitochondrial toxicity related to nucleoside analogue reverse transcriptase inhibitors in HepG2 cells[J].Antivir Ther,2003,8(5):463-470. 20 He L,Pu W,Liu X.et al.Proliferation tracing reveals regional hepatocyte generation in liver homeostasis and repair[J].Science,2021,371(6532):eabc4346. 21 Connolly GP,Duley JA.Uridine and its nucleotides:biological actions,therapeutic potentials[J].Trends Pharmacol Sci,1999,20(5):218-225. 22 Nwosu ZC,Ward MH,Sajjakulnukit P,et al.Uridine-derived ribose fuels glucose-restricted pancreatic cancer[J].Nature,2023,618(7963):151-158. |